Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - Other
Ratios

Bristol Myers Squibb (BMYMP) Receivables - Net (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Receivables - Net for 17 consecutive years, with $11.4 billion as the latest value for Q4 2025.

  • Quarterly Receivables - Net rose 6.21% to $11.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.4 billion through Dec 2025, up 6.21% year-over-year, with the annual reading at $11.4 billion for FY2025, 6.21% up from the prior year.
  • Receivables - Net for Q4 2025 was $11.4 billion at Bristol Myers Squibb, roughly flat from $11.4 billion in the prior quarter.
  • The five-year high for Receivables - Net was $11.4 billion in Q2 2024, with the low at $8.5 billion in Q1 2022.
  • Average Receivables - Net over 5 years is $10.2 billion, with a median of $10.2 billion recorded in 2023.
  • The sharpest move saw Receivables - Net fell 1.72% in 2022, then grew 18.13% in 2023.
  • Over 5 years, Receivables - Net stood at $9.4 billion in 2021, then increased by 5.52% to $9.9 billion in 2022, then increased by 10.47% to $10.9 billion in 2023, then decreased by 1.59% to $10.7 billion in 2024, then increased by 6.21% to $11.4 billion in 2025.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $11.4 billion, $11.4 billion, and $11.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.